Hester Biosciences Ltd (HESTERBIO) - Financial and Strategic SWOT Analysis Review

Hester Biosciences Ltd (HESTERBIO) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Hester Biosciences Ltd (Hester Biosciences) is an animal healthcare company and a manufacturer of poultry vaccines. It is committed to advancing animal health through research, development, and production of veterinary biologicals and pharmaceuticals. The company's product portfolio includes a wide range of vaccines and healthcare products that enhance the health and productivity of livestock, including cattle, sheep, and goats. It also offers solutions for poultry and companion animals, addressing various health concerns such as infections, reproductive health, and overall wellness. The company operates vaccine manufacturing plants in India, Nepal, and Tanzania, with a strong presence across Asia, Africa, Europe, and South America. Hester Biosciences is headquartered in Ahmedabad, Gujarat, India.

Hester Biosciences Ltd Key Recent Developments

May 17,2023: Hester Biosciences Announces Audited Financial Results for the Period Ended 31 March 2023
Mar 27,2023: Hester Biosciences: Outcome of Resolution passed by the Board Of Directors by circulation

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Hester Biosciences Ltd - Key Facts
Hester Biosciences Ltd - Key Employees
Hester Biosciences Ltd - Major Products and Services
Hester Biosciences Ltd - History
Hester Biosciences Ltd - Company Statement
Hester Biosciences Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Hester Biosciences Ltd - Business Description
Business Segment: Animal Healthcare
Overview
Performance
Business Segment: Others
Performance
Business Segment: Petcare
Overview
Performance
Business Segment: Poultry Healthcare
Overview
Performance
Geographical Segment: In India
Performance
Geographical Segment: Outside India
Performance
R&D Overview
Hester Biosciences Ltd - Corporate Strategy
Hester Biosciences Ltd - SWOT Analysis
SWOT Analysis - Overview
Hester Biosciences Ltd - Strengths
Hester Biosciences Ltd - Weaknesses
Hester Biosciences Ltd - Opportunities
Hester Biosciences Ltd - Threats
Hester Biosciences Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Hester Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Hester Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Hester Biosciences Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 17, 2023: Hester Biosciences Announces Audited Financial Results for the Period Ended 31 March 2023
Mar 27, 2023: Hester Biosciences: Outcome of Resolution passed by the Board Of Directors by circulation
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Hester Biosciences Ltd, Key Facts
Hester Biosciences Ltd, Key Employees
Hester Biosciences Ltd, Major Products and Services
Hester Biosciences Ltd, History
Hester Biosciences Ltd, Other Locations
Hester Biosciences Ltd, Subsidiaries
Hester Biosciences Ltd, Key Competitors
Hester Biosciences Ltd, Ratios based on current share price
Hester Biosciences Ltd, Annual Ratios
Hester Biosciences Ltd, Annual Ratios (Cont...1)
Hester Biosciences Ltd, Annual Ratios (Cont...2)
Hester Biosciences Ltd, Interim Ratios
Hester Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Hester Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Hester Biosciences Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Hester Biosciences Ltd, Performance Chart (2020 - 2024)
Hester Biosciences Ltd, Ratio Charts
Hester Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Hester Biosciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings